This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 May 2021 and includes updates on COVID-19, influenza, measles, Salmonella Braenderup,

This brief technical note was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe

Several SARS-CoV-2 variants have been identified. Some of these variants have mutations that (alone or in combination) may provide the virus with a selective advantage,

A new dashboard provides an overview of the proportion of SARS-CoV-2 variants of concern and variants of interest among sequenced samples in EU/EEA countries, as

This technical report provides a summary of the evidence available at the time of the publication and what will be required in the future to

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 May 2021 and includes updates on COVID-19, dengue and influenza.

The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage

The downloadable data files contain information on COVID-19 vaccination in the EU/EEA. The data are presented in the Vaccine Tracker and collected through The European

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 May 2021 and includes updates on COVID-19, Ebola virus disease, MERS-CoV,

The main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks, by SARS-CoV-2 variant and vaccine product.

This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in

ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the